CLINICAL_TRIALS
trial_result
· 2017-07-25
Clinical Trial Update: Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds [Phase 4]
Summary
Phase 4 study evaluating the pharmacokinetics and safety of Cambia (diclofenac potassium) in adolescents aged 12-17 with migraine has completed, with results po…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Depomed | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2017-07-25